Study finds restrictive clinical trial criteria excludes Lyme disease patients
New analysis of real-world data from the largest US Lyme disease registry, MyLymeData, has shown that most persistent Lyme disease…
Macro
-
-
Percheron plans to broaden pipeline following avicursen disappointment
Percheron Therapeutics has announced that it will investigate avicursen (ATL1102) in other indications besides Duchenne muscular dystrophy (DMD) following disappointing…
-
Xgene’s non-opioid analgesic reduces pain in Phase IIb trial
Taiwanese pharmaceutical company Xgene Pharmaceutical announced that its non-opioid analgesic drug XG005 has reduced acute pain in patients after surgery…
-
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity…
-
First patient dosed as Marengo’s invikafusp alfa trial expands to Europe
Clinical-stage biotechnology company Marengo Therapeutics has announced that it has dosed the first patient in Phase II of its STARt-001…
-
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
The RH5.1/Matrix-M blood-stage vaccine could constitute a crucial secondary defence for communities at high risk of malaria infection, including those…
-
APAC leading in Parkinson’s disease clinical trials
The Asia-Pacific (APAC) region is leading in the Parkinson’s disease clinical trial space globally with 44% of trials, according to…
-
CEPI funds safety project for vaccines in Africa
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced that it is providing up to $9.9m for a vaccine safety…
-
Generative AI has ‘potential to revolutionise clinical development’
Generative artificial intelligence (GenAI) has the potential to revolutionise clinical development – and certain key steps will help to unlock…
-
‘Major milestone’ for UK clinical trials as new framework laid in parliament
New legislation is being laid in the UK Parliament today (12 December) that will change the regulatory framework for clinical…
